We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
European Manufacturing Giant Selects Labvantage
News

European Manufacturing Giant Selects Labvantage

European Manufacturing Giant Selects Labvantage
News

European Manufacturing Giant Selects Labvantage

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "European Manufacturing Giant Selects Labvantage"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

LABVANTAGE has announced that an European manufacturing giant has selected its LIMS solution to replace its existing LIMS to meet GLP-requirements at its R&D headquarters. The solution will manage next generation product testing, part of the research and development pipeline, for key functionality such as stability testing, chemistry, and physicochemical testing. LABVANTAGE provides a user-friendly, intuitive and configurable GUI, delivered entirely via thin-client web browser. The new LIMS will also manage the facility’s extensive library of study protocols while enabling better decision making through its advanced reporting and analytics. LABVANTAGE’s Advanced Storage and Logistics, CAPA (Corrective Actions, Preventive Actions) and Connect Advanced Instrument Interface will also be deployed.

“This project provides an out-of-the-box LIMS solution that fully fits into the customer’s existing product life-cycle management process and further validates our investment into this part of the customer enterprise. We remain confident that our substantial investments into our own product portfolio will continue to extend our competitive differentiation in this legacy replacement market,” says Jeff Ferguson, LABVANTAGE Chief Executive Officer.
The implementation will be deployed in three phases: analysis request, logistics, and chemistry assessment-related analyses in phase one; product development support, batch release support and stability for phase two; and in vitro testing for phase three.

Advertisement